An interventional study of Acupuncture Laser Therapy in Hypertension, sponsored by Sinai University. Not yet recruiting at 2 sites in Egypt. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-08-04.
Sponsored by Sinai University · Not applicable, Interventional, and Treatment
The purpose of this study is to find the effect of acupuncture laser therapy on Blood Pressure in Hypertension Haemodialysis Patients
In patients with end-stage renal disease (ESRD) receiving dialysis, elevated blood pressure is common and poorly controlled in general. Although volume overload and sodium retention appear to be the main pathogenic mechanism of hypertension in this population, other factors such as increased arterial stiffness, activation of renin-angiotensin-aldosterone system, sleep apnea, activation of sympathetic nervous system, and use of recombinant erythropoietin may be also involved. Acupuncture laser therapy, which uses low-level laser treatment at specific acupuncture points, has shown promise in reducing blood pressure without invasive procedures. However, its specific efficacy in hemodialysis patients remains underexplored, necessitating this research
6,114 studies on the registry are indexed under Hypertension; 912 are open to participants now.
This study's planned enrollment of 60 is below the median of 100 across 4,575 interventional studies indexed under Hypertension.
Browse Hypertension studies →Sinai University is the lead sponsor of 24 studies on the registry; 11 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients receive Acupuncture Laser Therapy
Device: Acupuncture Laser Therapy
Application of low-level laser therapy to patients with chronic kidney disease to evaluate its effects on pain, circulation, and functional outcomes
Change in systolic and diastolic blood pressure
Blood pressure will be measured using a calibrated sphygmomanometer
Time frame: Baseline and after 4 weeks of low-level laser therapy
Blood pressure
Blood pressure will be measured using a calibrated sphygmomanometer
Time frame: Baseline and after 4 weeks of low-level laser therapy
Plan to share: No — Individual participant data will not be shared
Start is estimated for Aug 2026; primary completion for Oct 2027, 13 months later.
Of 1,403 non-industry interventional studies with no phase under Hypertension, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 13 months is below that.
Counting every sponsor, half of 1,498 studies reached it within 23 months; a quarter within 10 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sinai University